Position in LNTH
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,442
-$617,758 QoQ
Shares Held
13
-99.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#439
of 462 holders
Holding Since
Mar 2023
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TOTH FINANCIAL ADVISORY CORP holds $1,423,147 across 8 Drug Manufacturers - Specialty & Generic names. LNTH ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
20,725 | $1,325,363 | |
| 2 | ETON |
Eton Pharmaceuticals, Inc.
|
1,200 | $43,440 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
50 | $27,091 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,000 | $17,310 | |
| 5 | HLN |
Haleon plc
|
705 | $6,577 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
This page
|
13 | $1,442 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
35 | $1,185 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
150 | $739 |
All Filings in LNTH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,442 | 13 | Shares | Sole | 2026-07-14 | |
| 2023-03-31 | $619,200 | 7,500 | Shares | Sole | 2023-04-24 | |
| No filing history on record for this holder in this stock. | ||||||